The cannabis industry requires regulations to ensure that proceedings are ethical. But these regulations are not well developed yet. The industry is still in the early stages. The potential benefits of many CBD products are unverified. So the regulatory approach to CBD products has been amorphous.

So far, the FDA has only approved oneCBD product as a drug. This product works for the treatment of two epileptic disorders in children. Asides from this, other CBD products out in the market are uncertified for use as drugs. People sometimes assume that these products have been verified and adjudged to be safe by the FDA. Also, there are no standards for the preparation of these products yet. There are no quality control or quality assurance processes in place. So, these products sometimes come out tainted. There are reports that some products have had unsafe levels of contaminants such as heavy metals, THC, and pesticides.

Of course, since the safety of these products has not been verified, they may be unsafe for the public. Even with this uncertainty, they are being sold. Some studies have shown that CBD may have negative effects on male reproduction. With such data around, further studies are needed to determine the doses at which CBD products can be consumed. Also, more studies are needed in children and women to verify safety in that part of the population.

A couple of months back, the FDA had to issue warning letters to certain companies involved in the production of these products.It would seem that at the moment, the consumers and the producers are not very clear on what should be and what should not be. The marketplace contains CBD products incorporated into food products. Some products are even marketed as drugs. Some producers even took to spaces like social media and online stores to advertise these products. The FDA classifies them as inappropriate.